Mayo Clinic Health Manager
Get free personalized health guidance for you and your family.
Get StartedRisk factors
By Mayo Clinic staffAge is the most significant known risk factor for progressive supranuclear palsy. The disease typically affects people over the age of 60. Also, men are affected somewhat more often than women.
- NINDS progressive supranuclear palsy information page. National Institute of Neurological Disorders and Stroke. www.ninds.nih.gov/disorders/psp/psp_htm?css=print. Accessed Dec. 4, 2008.
- Progressive supranuclear palsy fact sheet. National Institute of Neurological Disorders and Stroke. www.ninds.nih.gov/disorders/psp/detail_psp.htm?css=print. Accessed Dec. 4, 2008.
- Karceski S. Progressive supranuclear palsy. Neurology. 2008;71:e70.
- Borroni B, et al. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology. 2008;71:1796.
- PSP: Some answers. Society for Progressive Supranuclear Palsy. http://www.psp.org/doc_library/1217970611/Some%20Answers.pdf. Accessed Jan.18, 2009.
- Treatments for progressive supranuclear palsy. Worldwide Education and Awareness for Movement Disorders. http://www.wemove.org/psp/psp_tre.html. Accessed Dec. 4, 2008.
- Josephs KA, et al. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Movement Disorders. 2003;18:1018.
- Josephs, KA. (expert opinion). Mayo Clinic, Rochester, Minn. Jan. 21, 2009.